Clinical Trials Directory

Trials / Terminated

TerminatedNCT03058211

Myocardial Injury and Severe Pneumococcal Pneumonia

Myocardial Injury in Severe Pneumococcal Pneumonia as a Cause of Mortality From Acute Cardiovascular Events

Status
Terminated
Phase
Study type
Observational
Enrollment
23 (actual)
Sponsor
Alejandro Rodriguez Oviedo , MD · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Accepted

Summary

Hypothesis: The "novo" cardiovascular events (CVE)in patients with severe community-acquired pneumonia (CAP) are frequent (17%) and could be associated with both direct pneumococcal myocardial invasion, toxin delivery (pneumolysin) or different biomarkers (histones, NETs(neutrophil extracellular traps), IL (Interleukin)-1b,h-Fabp (heart-Fatty acid bindding protein) ).The CVE frequency and its impact on outcome in patients without prior heart disease (CP) has not been studied. Objectives:1) To determine the incidence of myocardian injury (MI) and CVE in patients with CAP without CP evaluated by non-invasive techniques (Echocardiograph and MRI) and biomarkers levels (Tn-I (Troponin I), h-Fabp, NT-proBNP (N-terminal pro-brain natriuretic peptide) histones, NETs, IL 1b); 2) To assess if DMA and CVE are related to the etiology and their impact on outcome , 3) To investigate the presence of myocardial scarring by MRI and its relationship with etiology and MI, and 4) To identify prognostic factors of DMA and CVE to determine level of risk.

Detailed description

Area: Intensive care unit (ICU) of the participating hospitals. Patients: Forty patients with CAP without heart disease history will be included consecutively (20 patients with pneumococcal CAP and 20 patients with non-pneumococcal CAP).Ten healthy volunteers (controls) are included. Variables: Epidemiological, clinical and hemodynamic variables are recorded. Presence of MI and CVE measured by echocardiography and by biomarkers will be evaluated during the ICU stay. Presence of scarring miocardic by MRI technique will be determined at month 6 since ICU admission. Statistical analysis: Categorical (Fisher's exact test) and continuous variables( Wilconxon and Anova) will be used to determine differences between them. The Pearson correlation, ROC (discriminatory power) and logistic regression analysis(independent association) will be used to determine the association between variables and outcome. A p-value of 0.05 will be considered significant.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTEchocardiographyStandard protocols
DIAGNOSTIC_TESTCardiac Magnetic resonanceMRI with late gadolinium increase and T1 mapping

Timeline

Start date
2018-03-01
Primary completion
2019-05-31
Completion
2019-12-31
First posted
2017-02-20
Last updated
2021-07-01

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT03058211. Inclusion in this directory is not an endorsement.

Myocardial Injury and Severe Pneumococcal Pneumonia (NCT03058211) · Clinical Trials Directory